Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

May 31, 2026

Conditions
PsoriasisObesity
Interventions
DRUG

Ixekizumab

Administered SC

DRUG

Tirzepatide

Administered SC.

Trial Locations (72)

10023

Equity Medical, New York

10028

Mount Sinai Doctors - East 85th Street, New York

19462

Dermatology Associates of Plymouth Meeting, Plymouth Meeting

20850

Dermatology and Skin Cancer Specialists, LLC, Rockville

Lawrence J. Green, MD, LLC, Rockville

22206

Care Access - Arlington, Arlington

23502

Virginia Clinical Research, Inc., Norfolk

24541

Care Access - Danville, Danville

28078

Onsite Clinical Solutions - Huntersville, Huntersville

29212

Columbia Dermatology & Aesthetics, Columbia

32256

Solutions Through Advanced Research, Jacksonville

32771

International Clinical Research - Sanford, Sanford

33014

Deluxe Health Center, Miami Lakes

33016

NeoClinical Research, Hialeah

33021

Skin Care Research, Hollywood

33024

Encore Medical Research, Hollywood

33071

Life Clinical Trials, Coral Springs

33317

Leading Edge Dermatology, Plantation

33607

Nodal Medical Center, Tampa

33609

Palm Harbor Dermatology PA d/b/a TrueBlue Clinical Research, Tampa

33912

Alliance for Multispecialty Research, LLC, Fort Myers

34470

Renstar Medical Research, Ocala

35203

Total Skin & Beauty Dermatology Center, PC DBA Total Dermatology, Birmingham

37130

International Clinical Research - Tennessee LLC, Murfreesboro

37167

DelRicht Research - Thompson's Station, Smyrna

42104

Equity Medical - Bowling Green, Bowling Green

44512

Optima Research - Boardman, Boardman

45040

Dermatologists of Southwest Ohio, Mason

46168

The Indiana Clinical Trials Center, PC, Plainfield

46250

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

48167

MI Skin Innovations, Northville

48706

Great Lakes Research Group, Inc., Bay City

49316

The Derm Institute of West Michigan, Caledonia

58103

Red River Research Partners, Fargo

60563

Oak Dermatology, Naperville

60602

DeNova Research, Chicago

70601

Care Access - Lake Charles (Bayou Pines), Lake Charles

70809

DelRicht Research, Baton Rouge

72916

Johnson Dermatology, Fort Smith

75231

Modern Research Associates, PLLC, Dallas

77401

Bellaire Dermatology Associates, Bellaire

78213

Progressive Clinical Research, San Antonio

78218

Texas Dermatology and Laser Specialists, San Antonio

78229

Dermatology Clinical Research Center of San Antonio, San Antonio

78660

Austin Institute for Clinical Research, Pflugerville

78746

Tekton Research - Westlake Drive, Austin

84041

Tanner Clinic, Layton

85006

Medical Dermatology Specialists, Phoenix

85260

Scottsdale Clinical Trials, Scottsdale

85365

Yuma Clinical Trials, Yuma

89144

Las Vegas Dermatology, Las Vegas

89509

Skin Cancer and Dermatology Institute - Reno, Reno

90017

Metropolis Dermatology, Los Angeles

90045

Dermatology Research Associates, Los Angeles

91325

Northridge Clinical Trials, Northridge

92024

California Dermatology & Clinical Research Institute, Encinitas

92123

Therapeutics Clinical Research, San Diego

92677

Avance Clinical Trials, Laguna Niguel

92708

First OC Dermatology Research Inc, Fountain Valley

93030

Cura Clinical Research - Oxnard, Oxnard

95815

Integrative Skin Science and Research - Location 2, Sacramento

97201

Oregon Medical Research Center, Portland

97210

Oregon Dermatology and Research Center, Portland

98004

Bellevue Dermatology Clinic, Bellevue

98168

Dermatology of Seattle, Burien

03801

ActivMed Practices & Research, LLC., Portsmouth

08520

Psoriasis Treatment Center of Central New Jersey, East Windsor

07030

Care Access - Hoboken, Hoboken

00961

SCB Research Center, Bayamón

00985

Office of Dr. Alma M. Cruz, Carolina

00917

GCM Medical Group, PSC - Hato Rey Site, San Juan

00918

Mindful Medical Research, San Juan

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT06588283 - Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight | Biotech Hunter | Biotech Hunter